Validation of the Prevention Impacts Simulation Model (PRISM).


Journal

Preventing chronic disease
ISSN: 1545-1151
Titre abrégé: Prev Chronic Dis
Pays: United States
ID NLM: 101205018

Informations de publication

Date de publication:
04 02 2021
Historique:
entrez: 5 2 2021
pubmed: 6 2 2021
medline: 16 11 2021
Statut: epublish

Résumé

Demonstrating the validity of a public health simulation model helps to establish confidence in the accuracy and usefulness of a model's results. In this study we evaluated the validity of the Prevention Impacts Simulation Model (PRISM), a system dynamics model that simulates health, mortality, and economic outcomes for the US population. PRISM primarily simulates outcomes related to cardiovascular disease but also includes outcomes related to other chronic diseases that share risk factors. PRISM is openly available through a web application. We applied the model validation framework developed independently by the International Society of Pharmacoeconomics and Outcomes Research and the Society for Medical Decision Making modeling task force to validate PRISM. This framework included model review by external experts and quantitative data comparison by the study team. External expert review determined that PRISM is based on up-to-date science. One-way sensitivity analysis showed that no parameter affected results by more than 5%. Comparison with other published models, such as ModelHealth, showed that PRISM produces lower estimates of effects and cost savings. Comparison with surveillance data showed that projected model trends in risk factors and outcomes align closely with secular trends. Four measures did not align with surveillance data, and those were recalibrated. PRISM is a useful tool to simulate the potential effects and costs of public health interventions. Results of this validation should help assure health policy leaders that PRISM can help support community health program planning and evaluation efforts.

Identifiants

pubmed: 33544072
doi: 10.5888/pcd18.200225
pii: E09
pmc: PMC7879963
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

E09

Références

Ann Fam Med. 2017 Jan;15(1):37-47
pubmed: 28376459
JAMA Pediatr. 2014 Jun;168(6):561-6
pubmed: 24710576
Nutr J. 2013 Aug 08;12:116
pubmed: 23927718
Value Health. 2012 Sep-Oct;15(6):843-50
pubmed: 22999134
N Engl J Med. 2007 Dec 6;357(23):2371-9
pubmed: 18057339
Ann Fam Med. 2017 Jan;15(1):23-36
pubmed: 28376458
Am J Prev Med. 2015 Jul;49(1):102-11
pubmed: 26094231
Prev Chronic Dis. 2019 Jul 03;16:E87
pubmed: 31274409
N Engl J Med. 2011 Sep 29;365(13):e27
pubmed: 21913835
J Public Health Manag Pract. 2015 Jul-Aug;21(4):392-9
pubmed: 25084535
Prev Chronic Dis. 2016 Apr 07;13:E47
pubmed: 27055264
PLoS Med. 2017 Apr 18;14(4):e1002283
pubmed: 28419108
Health Promot Pract. 2013 Jan;14(1):53-61
pubmed: 22491443
J Public Health Manag Pract. 2016 Jul-Aug;22(4):360-9
pubmed: 26473434
Health Aff (Millwood). 2012 Jan;31(1):199-207
pubmed: 22232111

Auteurs

Benjamin Yarnoff (B)

RTI International, Research Triangle Park, North Carolina.
RTI International, 3040 E. Cornwallis Rd, Research Triangle Park, NC 27709. Email: byarnoff@rti.org.

Amanda Honeycutt (A)

RTI International, Research Triangle Park, North Carolina.

Christina Bradley (C)

RTI International, Research Triangle Park, North Carolina.

Olga Khavjou (O)

RTI International, Research Triangle Park, North Carolina.

Laurel Bates (L)

RTI International, Research Triangle Park, North Carolina.

Sarah Bass (S)

RTI International, Research Triangle Park, North Carolina.

Rachel Kaufmann (R)

Centers for Disease Control and Prevention, Atlanta, Georgia.

Lawrence Barker (L)

Centers for Disease Control and Prevention, Atlanta, Georgia.

Peter Briss (P)

Centers for Disease Control and Prevention, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH